Company Overview
Snapshot
Founded in March 2022 by Roy Rabinowitz and Omer Stoller, Kanso Diagnostics operates with 1–10 employees. The company has raised $1.5M across three funding rounds. In July 2024, Kanso Diagnostics secured a grant from TAU Ventures.
Business overview
Kanso Diagnostics is a Health Tech & Life Sciences company focused on developing a molecular testing platform for the diagnosis of bacterial and viral infections. Its proprietary technology offers PCR-grade accuracy for rapid home testing, aiming to transform the contemporary diagnostics experience by enabling accessible and easy-to-use at-home medical solutions. The platform is designed to detect multiple pathogens and genetic biomarkers from a single sample, significantly reducing diagnosis time from days to minutes, providing an end-to-end solution for infectious disease diagnosis anywhere, anytime.
Strategic signal
Kanso Diagnostics is poised for significant market impact with its innovative molecular testing platform, as highlighted by media attention in January 2025. Articles from TheMarker and Haaretz, along with a feature in FlipHTML5 in December 2024, emphasize the company's technology as "Faster, Simpler, Better" and an "Instant DNA test." This media validation signals growing recognition of Kanso's potential to disrupt the diagnostics industry by offering rapid, accurate, and accessible at-home testing solutions, positioning it as a key player in the evolving landscape of decentralized healthcare.
Log in to access full profile ›Company Intelligence Q&A
- When was Kanso Diagnostics founded?
- Kanso Diagnostics was founded in March 2022.
- Who are the founders of Kanso Diagnostics?
- The co-founders of Kanso Diagnostics are Roy Rabinowitz and Omer Stoller.
- What is Kanso Diagnostics' core technology?
- Kanso Diagnostics develops a proprietary molecular testing platform that accurately detects multiple pathogens and genetic biomarkers from a single sample, offering PCR-grade accuracy for rapid home testing of bacterial and viral infections.
- Has Kanso Diagnostics received any grants?
- In July 2024, Kanso Diagnostics secured a grant from TAU Ventures.
- What was a notable funding event for Kanso Diagnostics?
- In June 2023, Kanso Diagnostics received seed funding from Peregrine Ventures and Becton Dickinson. This funding contributed to the company's total of $1.5M raised across three funding rounds.